Compounded microdose tirzepatide, calibrated for active loss of 10 to 25 pounds. Not full dose. Not maintenance. The right dose for the rest of us. $189/month. No insurance required.
The same active ingredient as Mounjaro and Zepbound. Prescribed at the lower doses calibrated for adults actively losing 10 to 25 pounds. Not for severe obesity. Not for post-loss maintenance. The lane that did not exist until Sliver.
Full-dose tirzepatide and semaglutide were designed and approved for adults with a BMI of 30 or more. The dosing escalates to treat the hardest cases, and the side effects (nausea, fatigue, GI issues) scale with the dose.
Same molecule. Prescribed at the lower weekly doses that drive modest, sustained, active weight loss without the side effect profile of full-dose treatment. This is not the maintenance microdose other brands sell. This is the dose that actually moves the scale for adults with 10 to 25 pounds to lose.
No office visit, no blood test, no waiting rooms. We review the same clinical questions a provider would ask in person.
A US-licensed provider in your state reviews your responses, asks any clarifying questions, and writes your prescription.
Shipped from a state-licensed 503A compounding pharmacy in plain, discreet packaging. Refilled monthly. Cancel anytime.
If your provider determines Sliver is not the right fit, you will not be charged.
"I built Sliver after watching friends spend $300 a month on full-dose GLP-1s that were designed for severe obesity when all they wanted was to lose the last 15 pounds. The medication is the same. The dose should match the goal. That is the only protocol Sliver prescribes."
$189 per month. Provider review within 24 hours. Medication ships in 48 hours. Cancel anytime.
Take the 60-second assessment